Abstract
This synopsis is intended to provide policymakers with a brief summary of the latest demand forecasts for antimalarial drugs and the implications for health and development policy. The demand estimates are produced by a consortium of forecasters including The Boston Consulting Group, the Clinton Health Access Initiative, and the Fundacion Zaragoza Logistics Center. The consortium is funded by UNITAID and operates under the leadership of a steering committee consisting of the Affordable Medicines Facility—malaria, The Global Fund to Fight AIDS, Tuberculosis and Malaria, the Medicines for Malaria Venture, the Roll Back Malaria Partnership, UNITAID and the World Health Organization.
